Agostinis F, Tellarini L, Canonica GW, et al. Safety of sublingual immunotherapy with a monometric allergoid in very young children. Allergy 2005;60:133.

Ahn CN, et al. Local production of antigen-specific IgE in different anatomic subsites of allergic fungal rhinosinusitis patients. Otolaryngol Head Neck Surg 2009; 141:97-103.

Allam JP, et al. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008; 121:368-74.

Allergen Immunotherapy: Guidelines, Update and Recommendations of the World Health Organization, Theodoropoulos & Lockey, Allergy & Asthma Proc. Pg. 159-66, May-June 2000, Vol. 21, No. 3.

Am Academy of Allergy. Position statements: controversial techniques. J Allergy Clin Immunol 1981:333-8.

Amin HS, et al. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clinic Immunol 2006; 117:169-75.
Andre C, Fadel R. Anaphylxis caused by allergen sublingual immunotherapy? Allergy 2007; 62:1220-1.

Andre C, Perrin-Fayolle M, Grosclaude M, et al. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship. Int Arch Allergy Immunol 2003;131:111-8.

Andre C, Vatrinet C, Galvain S, et al. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229-34.

Andre, C. et al, "Safety of sublingual immunotherapy in children and adults," Int Arch Allergy Immunol Vol. 121, pgs. 229-234, 2000.
Antico, A. et al "Anaphylaxis by latex sublingual immunotherapy," Allergy, Vol. 61, pgs. 1236-1237, 2006.

Antico A, et al. Priming-like effect and successful desensitization after anaphylactic shock by latex sublingual immunotherapy. Eur Ann Allergy Clin Immunol 2007; 39:259-61.

Arikan, C et al,. "BCG-induced IL-12 did not improve parameters in asthmatic children treated with sublingual immunotherapy," Clinical and Exp. Allergy, 34-398-405, 2004.

Bagnasco M, et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectible routes in healthy human beings. J Alelrgy Clin Immunol 1997; 100:122-9.

Bagnasco M, et al. Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol 2005; 138:197-202.

Bahceciler NN, Isik U, Barian IB, et al. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind placebo-controlled study. Pediatr Pulmonol 2001;32:49-55.

Bellanti, Joseph and Russell Settipane, Editorial "Sublingual immunotherapy: A procedure whose time has come?" Asthma and Allergy Proceedings, Vol. 28, No. 1, pages 1-2, January-February 2007.

Bernardis P, Agnoletto M, Puccinelli P, et al. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55-62.

Bernhisel-Broadbent J. Diagnosis and management of food allergy. Curr Allergy Rep. 2001; 1(1): 67-75.

Bernstein Dl, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. 2004; 113: 1129-1136

Berto, Patrizia et al. "Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study," Annals of Allergy, Asthma and Immunology, Vol. 97, pgs. 615-621, November 2006.

Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008; 63:374.
Bock SA, et al. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001; 107: 191-193.

Bordignon V, Burastero SE. Multiple daily administration of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 2006; 97:158-63.

Bosquet J. The new ARIA guidelines: Putting science into practice. Clin Exp Allergy 2002; 2:38-43.

Bosquet J, and the ARIA Workshop Group. Allergic rhintis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (suppl 5):242-5.

Bousquet J, Lockey R. Malling HJ, Allergen Immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization Position Paper Allergy Vol 53 Suppl 44 pgs 1-29, 1998.

Bousquet J, Scheinmann P, Guinnepain MT, et al. Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999; 54:249-60.

Bousquet J. Local routes of immunotherapy. Arb Paul Ehrlich Inst Bundeaamt Sera Impfstoffe Frankf A M 1999;121-7; discussion 128-9.

Bousquet J. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms,. Allergy 2005; 61:1-3.

Bousquet, Jean, Editorial "Sublingual immunotherapy: Validated!", Allergy, Vol. 61, Issue S81, page 5, July 2006.

Bufe A, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-173.

Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498-504.

Burastero SE, et al. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production. Ann Allergy Asthma Immunol 2008; 100:343-50.

Burastero, Samuele E. "Sublingual immunotherapy for allergic rhinitis: an
update," Current Opinion in Otolaryngology & Head and Neck Surgery, Vol. 14, pgs. 197-201, 2006.

Caffarelli C, Sensi LG, Marcucci F, et al. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000;55:1142-7.

Calamita, Z. et al. "Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method," Allergy, Vol. 61, pgs. 1162-1172, 2006.

Canonica GW, Compalati E, Fumagalli F, et al. Sublingual and oral immunotherapy. Immunol Allergy Clin North Am 2004; 24:685-704.

Canonica GW, et al. Sublingual and oral immunotherapy. Immunol Allergy Clin North AM. 2004 Nov; 24(4): 685-704.

Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immuno 2003;111:437-48.; quiz 449.

Cassanovas M, Guerra F, Moreno C, et al. Double-blind, placebo-conrolled clinical trial of preseasonal treatment with allergic extracts of Olea europaea pollen administered sublingually. J Investig Allergol Clin Immunol 1994;4:305-14.

Castledine G. Nurse who failed to recognize the serious condition of a patient. Br J Nurs. 2002; 11(9): 602.

Cingi, C. et al. "Efficacy of long-term sublingual-oral immunotherapy in allergic rhinitis," ACTA Otorhinolaryngol Ital 25, pgs. 214-219, 2005.

Ciprandi G, Fenoglio D, Cirillo I, et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005; 95:38-44.

Ciprani, G. et Al "Sublingual immunotherapy and regulatory T-cells," Allergy Vol. 61, pgs. 511-513, 2006.

Clavel R, Bousquet J, Andre C. Clinical efficacy of sublingual-swallow immunotherapy; a double-blind, placebo-controlled trial of a standardized five-grass pollen extract in rhinitis. Allergy 1998;53:493-8.

Cox, Linda S "Sublingual immunotherapy, part 1: Review of Clinical Efficacy," The Journal of Respiratory Diseases, Vol. 28, No.4, pgs. 162-168, April 2007.

Cox, LS, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117:1021-35.

Cox, LS. Sublingual immunotherapy and allergic rhintitis. Curr Allergy Asthma Rep 2008; 8:102-110.

CSM update: Desensitizing vaccines. British Med J 1986; 293:948.
Curtis HH. The immunizing cure of hay fever. Med News, New York 1900; 77:16.

D. de Boissieu and C. Dupont "Sublingual immunotherapy for cow's milk protein allergy: a preliminary report," Allergy, Vol. 61, pgs. 1238-1239, 2006.

Dahl R, et al. Efficacy and safety of sublingual immunotherapy with grass alelrgen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118:434-40.

de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009; 64:963-4.

Dickey LW. Sublingual antigen testing and therapy for inhalants, foods, and petrochemicals. In Clinical Ecology. Dickey L (Ed). Springfield, IL:
Charles C. Thomas Publisher. 544-553, 1976.

Didier A, et al. Optimal dose, efficacy, and safety of once-daily subligual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J allergy Clin Immunol 2007; 120:1338-45.

Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33:206-10.

Di Rienzo V, Pagani A, Parmiani S, et al. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-3.

Di Rienzo V, Puccinelli P, Frati F, et al. Grass pollen specific sublingual/swallow immunotherapy in children: open-controlled comparison among different treatment protocols. Allergol Immunopathol (Madr) 1999;27:145-51.

Di Rienzo, V. et al, "Post-marketing surveillance study on the safety of sublingual immunotherapy in children," Allergy, Vol. 54, pgs. 1110-1113, 1999.

Di Rienzo, V. et al, "Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years," Clin Exp Allergy, Vol. 35, pgs. 560-564, 2005.

Diagnosis and management of rhinitis: parameter documents of the Joint Task Force on practice Parameters in Allergy, Asthma & Immunology. Ann Allergy 1998; 81(suppl):S463-S518.

Draca S. Prolactin as an immunoreactive agent. Immunol Cell Biol 1995;73:481-3.

Dunsky, E.H. et al "Anaphylaxis to sublingual immunotherapy," Allergy, Vol. 61, pgs. 1235-1244, 2006.

Durham SR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117:802-9.

Eifan AO, et al. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 2007; 62:567-8.

Eigenmann PA, et al. An internet-based survey of anaphylactic reactions to food. Allergy. 2001; 56: 540-543.

Emanuel IA, et al. Under treatment of allergy: Exploring the utility of sublingual immunotherapy. Otolaryngol Head Neck Surg 2009; 140:615-21.
Esch RE. Sublingual immunotherapy. Curr Op Otolaryngol Head Neck Surg 2008; 16:260-264.

Fanta C, Bohle B, Hirt W, ct al. Systemic immunological changes induced by administation of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999; 120:218-24.

Feliziani V, Lattuada G, Parmiani S, et al. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:224-30.

Finegold, Ira "Allergen immunotherapy; Present and future," Asthma and Allergy Proceedings, Vol. 28, No. 1, pgs. 44-49, January-February 2007.
Food allergy: a practice parameter. Ann Allergy 2006; 96(3):S1-S68.

Frew, Anthony J., M.D. "Sublingual Immunotherapy." The New England Journal of Medicine. Volume 358:2259-2264. May 22, 2008.

Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin. Ther. 1984; 6(5):592-599.

Grosclaude M, Bouillot P, Alt R, et al. Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study. Int Arch Allergy Immunol 2002;129:248-53.

Grosclaude, M, et al, "Safety of Various Dosage Regimens during Induction of Sublingual Immunotherapy," International Archives Allergy and Applied Immunology, Vol. 129 (3), pgs. 248-253, March 2003.

Guarderas J. Is it food allergy? Postgrad Med. 2001; 109(4): 125-132.
Guez S, Vatrinet C, Fadel R, et al. House-dust mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55:369-75.

Haruhiko Yagi, Takashi Nomura, Kyoko Nakamura, Sayuri Yamazaki, Toshio Kitawaki, Shohei Hori, Michiyuki Maeda, Masafumi Onodera, Takashi Uchiyama, Shingo Fujii, and Shimon Sakaguchi. August 2004. "Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells." International Immunology, Vol. 16, No. 11, pp. 1643-1656.

Hasan, H., et al, "Short Report - Evaluation of Immunotherapy for Seasonal and Perennial Allergic Rhinitis Using Quality of Life Questionnaires," Current Allergy & Clinical Immunology, Vol. 16, No. 1, March 2003.

Hayden RC, Gordon BR, Allergy and Immunology An Otolaryngic Approach. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p. 451.

Hirsch T, Sahn M, Leupoid W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8:21-7.

Horak F, et al. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. Clin Exp Allergy 2008; 39:394-400.

Horak F, Stubner P, Berger UE, et al. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin Immunol 1998;8:165-71.

Hordijk GJ, Antvelink JB, Luwema RA, Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Allergol Immunopathol (Madr) 1998;26:234-40.

Hordijk, G.J., et al, "Sublingual immunotherapy with a standardized grass pollen extract; a double-blind placebo-controlled study," Allergol, et Immunopathol., Vol. 26, No. 5, pages234-240.

Huang CF, et al. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic Th2 immune responses and mucosal immunity in mice. Ann Allergy Asthma Immunol 2007; 99:443-52.

Hurst DS, Gordon BR, Fornadley JA, et al. Safety of home-based and office allergy immunotherapy: a multicenter prospective study. Otolaryngol Head Neck Surg 1999; 121:553-61.

Incorvaia, Cristoforo; Frati, Franco; Puccinelli, Paola; Marcucci, Francesco; Di Cara, Giuseppe; Sensi, Laura; Scurati, Silvia; Yacoub, Mona-Rita; Moingeon, Philippe. "Effects of Sublingual Immunotherapy on Allergic Inflammation." Inflammation & Allergy - Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy), Vol. 7, No. 3, September 2008, pp. 167-172(6).

J Investig Allergol Clin Immunol. 2008; 18(4):233-8.
James, JM. Anaphylactic reactions to foods. Immunol Allergy Clin NA. 2001; 21(4): 653-667.

Joint Task Force on Practive Parameters. Allergen immunotherapy: A practice parameter. Ann Allergy Asthma Immunol 2003; 90:1-40.

Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002; 49(6):897-903.

Kerzl, Regina et al "Life-threatening anaphylaxis to kiwi fruit: Protective sublingual allergen immunotherapy effect persists even after discontinuation," Letter to the Editor, J Allergy Clinic Immunol, 2006.

Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:45-53.

Kleine-Tebbe J, et al. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized placebo-controlled trial. Allergy 2006; 61:181-4.

Koepp SK, et al. Predictive value of modified quantitative testing in sublingual immunotherapy outcomes. Presented at the annual meeting of the American Academy of Otolarngic Allergy, Chicago, Illinois, September 2008.

La Rosa M, Ranno C, Andre C, et al. Double-blind placeo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104(2 Pt 1):425-32.

Lahat N, Miller A, Shtiller R, et al. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993;47:35-40.

Lambrecht, BN "Dendritic cells in the pathogenesis of asthma" Clinical and Exp. Allergy Rev 2004, 4:123-128.

Larenas-Linnemann DE. Subcutaneous and sublingual immmunotherapy in children: complete update on controversies, dosing, and efficacy. Curr Allergy Asthma Rep 2008; 8:465-74.

Larenas-Linnemann DE. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy. Allergy Asthma Proceedings. 2008; 29:130-9.

Leatherman BD. AAOA consensus sublingual immunotherapy dosing protocol. American Academy of Otolaryngol Allergy Medical Update 2007; Winter:3-4.
Leatherman B. Injection and sublingual immunotherapy in the management of allergies affecting the unified aiway. Otolaryngic Clin N Amer 2008; 41:359-74.

Leatherman BD, et al. Sublingual immunotherapy: Past, present, paradigm for the future? Otolaryngol Head Neck Surg 2007; 136:S1-S20.

Lehman CW. A double-blind study of sublingual provocative food testing: a study of its efficacy. Ann Allergy 1980; 45:144-9.

Lehman CW. A double-blind study of sublingual provocative food testing: a study of its efficacy. Ann Allergy 1980; 45:144-9.

Lichtenstein L, Norman P, Winkenwerder W. et al. In vitro studies of human ragweed allergy changes in cellular and humoral activity associated with specific desensitization. J Clin Invest 1966; 45:1126-1136.

Lima MT, Wilson D, Pitkin L, et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial Clin Exp Allergy 2002;32:507-14.

Lockey RF, Benedict LM. Turkeltaub PC, et al. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79:660-77.

Lockey RF, et al. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol. 2001; 87(Suppl):47-55.

Lombardi C, Canonica GW, Passalacqua G. Sublingual IT in OAS. Allergy 2000;55:677.

Lombardi C, et al. Administration regimens for sublingual immunotherapy to pollen allergens: What do we know? Allergy 2009; 64:849-54.

Lombardi C, et al, "Sublingual immunotherapy is clinically safe in patients with oral allergy syndrome," Allergy 2000 in press.

Lombardi C, Gani F, Landi M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004;113:1219-20.

Lombardi C, Gargioni S, Melchiorre A, et al. Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study. Allergy 2001;56:989-92.

Lue KH, et al. Clinical and immunological effects of sublingual immunotherapy in asthmatic children sensitized to mites: A double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006; 17:408-15.

Madonini, E. et al, "Safety and Efficacy Evaluation of Sublingual Allergen-Specific Immunotherapy - A Retrospective, Multicenter Study, International Journal of Immunopathology and Pharmacology, Vol. 13, No. 2, pgs. 77-81, 2000.

Malling HJ, et al. EAACI position paper on local immunotherapy. Allergy 1998; 53:933.

Malling HJ, et al. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis. Clin Exp Allergy 2008; 39:387-93.

Malling HJ, et al. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets. J investig Allergol Clin Immunol. 2006; 16(3): 162-168.

Malling HJ. Is Sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002; 2:523-31.

Malling, H-J, "Sublingual immunotherapy: Efficacy - methodology and outcome of clinical trials," Allergy, Vol. 61, (Suppl. 81), pages 24-28, 2006.

Marcucci F, Sensi L, Frati F, et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monoscrisitized to mites. Allergy 2003;58:657-62.

Marogna M et al. "Long-Lasting Effects of Sublingual Immunotherapy for House Dust Mites in Allergic Rhinitis with Bronchial Hyperreactivity: A Long-Term (13-Year) Retrospective Study in Real Life," Int Arch Allergy Immunol, Vol. 142, (1) pages 70-78, October 2006.

Marogna M, et al. Preventative effects of sublingual immunotherapy in childhood: An open randomized controlled study. Ann Allergy Asthma Immunol 2008; 101:206-10.

Marogna, Maurizio et al. "Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients," Annals of Allergy, Asthma & Immunology, Vol. 98, pgs. 274-280, March 2007.

Marogna M, et al. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol 2009; 102:69-75.

Montgomery DW, Krumenacker JS, Buckley AR, Prolactin stimulatea phosphorylation of the human T-cell antigen receptor complex and ZAP-70 tyrosine kinase: a potential mechanism for its immunomodulation. Endocrinology 1998;139:811-4.

Morris DL. Use of sublingual antigen in diagnosis and treatment of food allergy. Ann Allergy 1969; 27:289-94.

Morris DL. Use of sublingual antigen in diagnosis and treatment of food allergy. Ann Allergy 1969; 27:289-94.

Morris DL. Use of sublingual antigen in diagnosis and treatment of food allergy. Ann Allergy 1969; 27:289-94.

Morris, D.L. "Current use of sublingual-swallow immunotherapy," Current Opinion in Otolaryngology &Head and Neck Surgery, Vol. 9, No. 3, pgs. 179-180, June 2001.

Mortemousque B, Bertel F, De Casamayor J, et al. House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2003;33:464-9.

Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma: a placebo controlled study. Ann Allergy Asthma Immunol 1999;82:485-90.

Nelson HS, Oppenheimer J, Vataia GA, et al. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Investig Allergol Clin Immunol 1993;92:229-36.

Novembre E, Galli E, Landi F, et al. Coscasonal sublingual immunotherapy reduces the development of asthma in children with allergic rinoconjunctivitis. J Allergy Clin Immunol 2004;114:851-7.

Nucera, E. "Immunological Aspects of Oral Desensitization for Nickel," Cutis, Vol. 61, No. 3, pgs. 129-132. March 1998.

O'Hehir RE, et al. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparations. Curr Medicinal Chemistry 2007; 14:2235-44.

Olsen O, Middleton P, Ezzo J, et al. Quality of Cochrane reviews: assessment of sample from 1998. BMJ 2001; 323:829-32.

Ongari S, Domeneghetti P, Parmiani S, Comparison among drugs, injective IT and sublingual IT in grass allergic patients. Allergy 1995;50:358.

Ostergaard PA, Kaad PH, Kristensen T. A prospective study on the safety of immunotherapy in children with severe asthma. Allergy 1986;41:588-93.

Ott H, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after the cessation of treatment: the ECRIT study. Allergy 2009; 64:179-86.

Paganelli R, Cavagni G, Pallone F. The role of antigenic absorption and circulating immune complexes in food allergy. Ann Allergy 1986; 57:330-6.

Pajno GB, Morabito L, Barberio G, et al. Clinical and immunologic effects of long-term sublingual immunotherapy in sthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842-9.

Pajno GB, Peroni DG, Barberjo G, et al. Efficacy of sublingual immunotherapy in asthma and eczema. Chem Immunol Allergy 2003;82:77-88.

Pajno, Giovanni "Sublingual immunotherapy: The optimism and the issues," Journal of Allergy and Clin Immunol, Vol. 119, No. 4, pgs. 796-801, April 2007.
Passalacqua G and G. Walter Canonica "Sublingual immunotherapy: Update 2006,

Passalacqua G, et al. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol. 2004 Jul; 93(1): 3-12.

Passalacqua G, et al. New insights in sublingual immunotherapy. Curr Allergy Asthma Rep. 2006 Sep; 6(5): 407-412.

Passalacqua G, et al. Safety profile of sublingual immunotherapy. Treat Respir Med. 2006; 5(4): 225-234.

Passalacqua G, Venturi S, Ziccali P, et al. Oral and sublingual immunotherapy: general aspects and critical considerations. Wien Med Wochenschr 1999;149:433-7.

Passalacqua, G et al. "Allergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy," Journal of Allergy and Clin Immunol, Vol. 119, No. 4, pgs. 881-891, April 2007.

Passalacqua, Giovanni, et al. "New Insights in Sublingual Immunotherapy," Current Allergy and Asthma Reports, Vol. 6, pgs. 407-412, 2006.

Patriarca C, Romano A, Venuti A, et al. Oral specific hyposensitization in the management of patients allergic to food. Allergol Immunopathol (Madr) 1984; 12:275-81.

Patriarca G, Schiavino D, Nucera E, et al. Food allergy in children: results of a standardized protocol for oral desensitization.
Hepatogastroenterology 1998; 45:52-8.

Patriarca, G. "Sublingual Desensitization: A New Approach to Latex Allergy Problem" Anesth Analg, Vol. 95, pgs. 956-960, 2002.

Patriarca, G. et al,. " Oral desensitizing treatment in food allergy: clinical and immunologic results," Ailment Pharmacol Ther, Vol 17, pgs. 459-465, 2003.

Patriarca, G., et al,. "Food allergy in children: results of a standardized protocol for oral desensitization," Hepatogastroenterology, Vol. .45 (19): pgs. 52-58, January-February 1998.

Penagos M, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: A meta-analysis of randomized, placebo-controlled double blind trials. Ann Allergy Asthma Immunol 2006; 97:141-8.

Penagos M, et al. Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 year of age. Chest 2008; 133: 599-609.

Peterson R, Good R. Antibodies to cow's milk proteins: their presence and significance, Pediatrics 1963; 31:209-21.

Piazza I, Bizzaro N. Humoral respronse to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to dermatophagoldes pteronyssinus. Ann Allergy 1993;71:461-9.

Pradalier A, Basset D, Claudel A, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass pollen extract (dropsand sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-28.

Purin MJ, Norman PS, Crcticos PS, et al. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991; 88:27-32.

Quirino T, Lemoli B, Siciliani B, et al. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:1253-61.

Radulovic S, et al. Sublingual immunotherapy for allergic rhinitis: an updatd Cochrane systematic review and meta-analysis. Allergy 2007; 62 (S83):167-551, abstract 727.

Reid MJ, Lockey RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92(1 Pt 1):6-15.

Rienzo VD, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy. 2005 May; 35(5): 560-564.

Robinson A. Research, practice and the Cochrane Collaboration. CMAJ 1995; 152:883-9.

Roblin DG, et al. What, if any, is the value of septal surger? Clin Otolaryngol Allied Sci 2007; 27:77-80.

Rodriguez F, et al. Once daily sublingual immunotherapy without updosing: a new treatment schedule. Int Arch Allergy Immunol 2006; 140:321-6.

Rolinck-Werninghaus C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy. 2004 Dec; 59(12): 1285-1293.

Rolinck-Werninghaus C, Wolf H, Licbke C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004;59:1285-93.

Sabbah A, Hassoun S, Le Sellin J, et al. A double-blind, placebo-controlled trial by the su lingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13.

Sabra A, Bellanti JA, Rais JM, et al. IgE and non-IgE food allergy, Ann Allergy Asthma Immunol 2003; 90(suppl 3):71-6.

Salvolainen J, et al. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PMBC. Allergy 2006; 61:1184-90.

Sambugaro R, Puccinelli P, Burastero SE, et al. The efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase. Allergol Immunopathol (Madr) 2003;31:329-37.

Saporta D. Sublingual Immunotherapy: A novel, albeit not so new, immunotherapy treatment modality. Am J Rhinol 2008; 22:253-7.

Saporta D, McDaniel AB. Efficacy comparison of multiple-antigen subcutaneous injection immunotherapy and multiple-antigen sublingual immunotherapy. Ear Nose Throat J 2007; 86:493-7.

Scadding GK, et al. BSACI guidelines for the management of allergic and non-allergic rhintitis. Clin Exp Allergy 2008; 38:19-42.
Sicherer SH and Sampson HA. Food allergy. J Allergy Clin Immunol. 2006; 117(2): S470-S475.

Silvestri M, Spallarossa D, Battistini E, et al. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy. J Investig Allergol Clin Immunol 2002; 12:52-9.

Smith H, White P, Annila I, et al. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004; 114:831-7.

Smith TL, et al. Predicitve factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2005; 115:2199-205.

Stelmach I, et al. Efficacy and safety of high-dose sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2008; 39:401-8.

Stempel DA. The health and economic impact of rhinitis: A roundtable discussion. Am J Managed Care 1997; 3:8-18.

Stewart GE 2nd, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol1992;90(4 Pt 1):567-78.

Stewart GE, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 1992; 90:567-78.

Sublingual immunotherapy (SLIT) udate. AAOA Today Bulletin. Winter 2009:2-3.

Tamir R, Castracane JM, Rocklin RB. Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. J Allergy Clin Immunol 1987; 79:591-8.

Tari MG, Mancino M, Madonna F, et al. Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 1994; 22:209-16.

Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990;18:277-84.

Tari, M.G., et al,. "Immunologic evaluation of 24 month course of sublingual immunotherapy." Allergol. Et Immunopathol., Vol. 22, No. 5, pgs. 209-216, 1994.

The diagnosis and management of anaphylaxis: an update practice parameter. J Allergy Clin Immunol 2005; 115(3): S483-S523.

Thien PC, Walters EH.Eicosanoids and asthma: an update. Prostaglandins Leukot Essent Fatty Acids 1995;52:271-88.

Tinkeiman DG, Cole WQ 3rd, Tunno J, Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995;95(1 Pt 1):8-14.

Tonnel AB, Scherpereel A, Douay B, et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004;59:491-7.

Troise C, Voltolini S, Canessa A, et al. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study. J Investig
Allergol Clin Immunol 1995;5:25-30.

Valovirta E, et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy. 2006 Oct; 61(10); 1177-1183.

Vervloet D, Birnbaum J, Laurcat P. Safety and clinical efficacy of rush sublingual cypress immunotherapy: preliminary results. Allergy 2002;57(suppl):70.

Voltolini S, Modena P, Minale P, et al. Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol (Madr) 2001;29:103-10.

Wahn U, et al. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123:160-6.

Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
Wilson DR, Torres LI, Durham SR, Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003; CD002893.

Wise SK, et al. Antigen-specific IgE in the sinus mucosa of allergic fungal rhinosinusitis patients. Am J Rhinol 2008; 22:451-6.

Wise SK, et al. Quality of life outcomes with sublingual immunotherapy. Amer J Otolaryngol. In press.

Woody J, et al. Clinical Improvement after rapid escalation for sublingual immunotherapy: A pilot study. Ear Nose Throat J. In press.

Wuthrich B, Bucher C, Jorg W, et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003;13:145-8.

Yufeng Peng, Yasmina Laouar, Ming O. Li, E. Allison Green, and Richard A. Flavell. March 2004. "TGF-B regulates in vivo expansion of FOXP3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes." Proceedings of he National Academy of Sciences of the United States of America. Vol 101. No. 13. p. 4572-4577.

The E.W. Scripps Co. 2009. http://www.dailycamera.com. May 26, 2009. http://www.dailycamera.com/news/2009/may/26/allergy-drops-shots-effective-FDA/